Please enable Javascript
The HemOnc Pulse
Meeting News
The HemOnc Pulse Live
Video Insights
In Print
Subscribe
Leukemia
Acute Lymphoblastic Leukemia
Acute Myeloid Leukemia
Chronic Lymphocytic Leukemia
Chronic Myeloid Leukemia
Lymphoma
Aggressive B-Cell Lymphoma
Hodgkin Lymphoma
Indolent B-Cell Lymphoma
Mantle Cell Lymphoma
T-Cell Lymphoma
MPN
Myelofibrosis
Polycythemia Vera
MDS
Myeloma
Transplantation & Cellular Therapy
Heme Today
Menu
Wendy Stock, MD
Articles by Wendy Stock, MD
Long-Term Outcomes and Innovations in Frontline ALL
Wendy Stock, MD
Meeting News
|
June 25, 2025
Immunotherapy is reshaping ALL care, and short blinatumomab use may boost outcomes and reduce chemo-related toxicity.
View More
‘The HemOnc Pulse’ Live: What Are the Unanswered Questions in ALL?
Chadi Nabhan, MD, MBA, FACP
The HemOnc Pulse Live
|
May 23, 2024
The panel discussed ALL treatment, associated toxicities, and the possibility of a chemotherapy-free approach.
Listen Now